| HMS | hexose monophosphate shunt; hypermobility syndrome |
|---|---|
| IS | ileal segment; immediate sensitivity; immune serum; immunosuppression; impingement syndrome; incenti... |
| MAS | magic angle spinning; Manifest Anxiety Scale; maximum average score; McCune-Albright syndrome; mecon... |
| MCS | malignant carcinoid syndrome; managed care system; massage of the carotid sinus; mesocaval shunt; me... |
| PCS | palliative care service; Patient Care System; patterns of care study; pelvic congestion syndrome; ph... |
| portacaval shunt, surgical | Surgical portasystemic shunt between the portal vein and inferior vena cava. (12 Dec 1998) |
|---|---|
| portasystemic shunt | A shunt between any parts of the portal and systemic venous systems, including portacaval, mesocaval, splenorenal shunt's or spontaneously occurring shunt's. (05 Mar 2000) |
| portasystemic shunt, surgical | Surgical venous shunt between the portal and systemic circulation to effect decompression of the portal circulation. It is performed primarily in the treatment of bleeding oesophageal varices resulting from portal hypertension. Types of shunt include portacaval, splenorenal, mesocaval, splenocaval, left gastric-caval (coronary-caval), portarenal, umbilicorenal, and umbilicocaval. (12 Dec 1998) |
| portasystemic shunt, transjugular intrahepatic | A type of surgical portasystemic shunt to reduce portal hypertension with associated complications of oesophageal varices and ascites. It is performed percutaneously through the jugular vein and involves the creation of an intrahepatic shunt between the hepatic vein and portal vein. The channel is maintained by a metallic stent. The procedure can be performed in patients who have failed sclerotherapy and is an additional option to the surgical techniques of portocaval, mesocaval, and splenorenal shunts. It takes one to three hours to perform. (jama 1995;273(23):1824-30) (12 Dec 1998) |
| hexose monophosphate shunt | The main metabolic pathway in activated neutrophils, rendering them relatively insensitive to inhibitors of oxidative phosphorylation. Congenital deficiency of the first enzyme in the shunt, glucose 6 phosphate dehydrogenase, produces a sensitivity to infection similar to that seen in chronic granulomatous disease. (18 Nov 1997) |
| Scribner shunt | Connection of an artery, customarily the radial, to the cephalic vein via a short extracorporeal catheter. (05 Mar 2000) |
| H shunt | <surgery> A side-to-side shunt between adjacent vessels which utilises a connecting conduit. Synonym: H graft. (05 Mar 2000) |
| shunt | 1. To turn to one side, to divert, to bypass. 2. <cardiology> A passage or anastomosis between two natural channels, especially between blood vessels. Such structures may be formed physiologically (for example to bypass a thrombosis) or they may be structural anomalies. 3. <surgery> A surgically created anastomosis, also, the operation of forming a shunt. (18 Nov 1997) |
| shunt, left to right | A term used to describe the diversion of blood from the higher pressure left side of the heart to the right side (pulmonary circuit). Can be seen in ventricular septal defect, atrial septal defect and patent ductus arteriosus (congenital at birth). (27 Sep 1997) |
| shunt, right to left | <cardiology> A term used to describe the diversion of blood from the right side of the heart to the left. Long standing left to right shunts can lead to increased right sided pressures in the pulmonary circuit (pulmonary hypertension). Eventually the left to right shunt reverses and blood flows from the right to the left. Can be seen in large untreated ventricular septal defect or atrial septal defect. (27 Sep 1997) |
| splenorenal shunt | Anastomosis of the splenic vein to the left renal vein, usually end-to-side, for control of portal hypertension. Synonym: renal-splenic venous shunt. (05 Mar 2000) |
| splenorenal shunt, surgical | Anastomosis of splenic vein to renal vein to relieve portal hypertension. (12 Dec 1998) |
| Denver shunt | LeVeen-type shunt with an implanted, valved, manually compressible chamber used to determine and maintain patency. (05 Mar 2000) |
| dialysis shunt | Arteriovenous shunt connecting the arterial and venous cannulas in arm or leg. (05 Mar 2000) |
| Dickens shunt | <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate. Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses. In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection. Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose. (18 Nov 1997) |